Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BofA

Bank of America sees stagflation, not recession—and no rate cut this year. It’s because of 2 specific Trump policies

It all comes down to the labor market, immigration, and tariffs. What is really going on in terms of how many workers are available?

Fortune

As Super Micro Computer Stock Absolutely Plunges, Should You Buy the SMCI Dip?

Super Micro stock tanks on disappointing Q4 earnings and weaker-than-expected guidance. Here’s why SMCI shares aren’t worth buying on the post-earnings decline.

Barchart

Here’s what the doomsayers are getting wrong about the job market, according to a Wall Street veteran

“This implies that the weak gains in payrolls in recent months might have something to do with the supply of labor.”

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Ford's Q2 Shines, But Analysts Warn Of Recall Hangover And Cost Pressures

Ford Motor Company (NYSE:F) shares are trading higher on Thursday after the automaker posted second-quarter results that exceeded Wall Street expectations on Wednesday, driven by solid vehicle volumes and favorable pricing trends.

Benzinga

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

Benzinga

‘Not just a cyclical recovery, but a boom.’ BofA says a ‘key tail risk’ is that the Trump economy will actually start to take off

“Today a confluence of factors argue that the key tail risk that may not be priced in is not just a cyclical recovery, but a boom,” BofA Research analysts write.

Fortune

Elevidys Halt Sparks Analyst Downgrades—Sarepta Races To Revise Label

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced Monday it will voluntarily and temporarily pause all U.S. shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, effective July 22.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is Bank of America Stock a Buy, Sell, or Hold After Q2 Earnings?

Is BofA’s Q2 revenue miss just a brief pause? Or a warning sign to rethink your position?

Barchart

Quantum computing is so fire — No, seriously. BofA says it could be humanity's biggest breakthrough since the discovery of fire

"A technology that can perform endless complex calculations in zero-time, warp-speeding human knowledge and development."

Fortune

Why Morgan Stanley Offers A Compelling Long-Term Investor Story

Morgan Stanley (NYSE:MS) on Wednesday reported a second-quarter 2025 earnings of $2.13, up from $1.82 a year ago and beating the consensus of $2.02.

Benzinga

London stocks slip after reports that Trump will fire Federal Reserve boss

The FTSE 100 index closed down 11.77 points, 0.1%, at 8,926.55.

Evening Standard

Americans spend $40 billion on their pets’ health care. Chewy has a plan to get more of their money

Americans adopted roughly 23 million pets during the pandemic, and Bank of America Research sees the "COVID cohort" nearing middle age.

Fortune

S&P 500 Defies Odds With Rare Rally — But 'Toppy' Sentiment Creeps In

The U.S. stock market has just completed one of its strongest three-month runs in history, with the SP 500 soaring 26% between April 9 and July 10, a pace of gains rarely seen. While historical analogues suggest further upside, signs of overheated investor sentiment are starting to worry market watchers.

Benzinga

Honeywell Set To Soar? Analyst Says Smart Price Hikes, Solid Backlog, M&A Could Drive Big Gains

BofAmerica Securities analyst Andrew Obin maintained a Buy on Honeywell International (NASDAQ:HON) and increased the price target from $250 to $275 on Monday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?

Bristol-Myers Squibb Co. (NYSE:BMY) is gearing up to announce its second-quarter 2025 earnings on July 31, with expectations for adjusted earnings of $1.585 per share on sales of $11.31 billion, according to data from Benzinga Pro.

Benzinga

Southwest Airlines Adds St. Thomas To Growing Caribbean Network

Southwest Airlines Co. (NYSE:LUV) plans to expand its route network in 2026, starting with new service to Cyril E. King International Airport (STT) in St. Thomas, U.S. Virgin Islands.

Benzinga

Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast

Bank of America dropped its top 10 stock ideas for the third quarter of 2025, and the list includes some familiar names like Boeing Co. (NYSE:BA) and Cisco Systems Inc. (NASDAQ:CSCO)—but also a couple of bearish calls investors might not see coming.

Benzinga

How Trump's Student Loan Reform Could Funnel Billions In Loans To SoFi

SoFi Technologies Inc. (NASDAQ:SOFI) has seen its stock soar by approximately 45% in the past month, fueled by potential legislative changes that could significantly reroute student loan demand from federal programs to private lenders.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

BofA Sticks With Overweight On Costco, Sees Easing Headwinds Ahead

On Wednesday, Costco Wholesale Corp (NASDAQ:COST) reported net sales of $26.44 billion for the retail month of June, which includes the five-week period ending July 6.

Barchart

Nvidia Just Became the First $4 Trillion Company in the World. Should You Buy NVDA Stock?

Nvidia extended gains to become the world’s first $4 trillion company on Wednesday. BofA analyst still sees further upside in NVDA shares.

Barchart

This Chinese Stock Just Launched Something That Could Be Even Bigger and More Powerful Than DeepSeek

Baidu says its ERNIE 4.5 AI models are now freely available under the Apache 2.0 license. BofA sees upside in BIDU shares to $100.

Fortune

Bank of America says tariffs might spark a ‘reshoring’ boom—but experts say it might be a double-edged sword for the economy

A lack of skilled labor in the U.S. could force companies to invest more heavily in automation.

Fortune

BofA analyst raises price target for Citi to $100, takes bullish view of Fraser’s restructuring

The analyst said recent changes are paying off and making the bank more competitive

Benzinga

Unity Software Stock Is Sliding Today: What's Going On?

Unity Software Inc (NYSE:U) shares are trading lower Thursday. BofA Securities reinstated coverage with an Underperform rating.

Fortune

Agentic AI spending could reach $155 billion by 2030, say BofA analysts

There's a growing belief that agentic AI could fundamentally transform workforce productivity.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.